| Primary |
| Hypertension |
41.4% |
| Type 2 Diabetes Mellitus |
10.7% |
| Product Used For Unknown Indication |
8.2% |
| Diabetes Mellitus |
5.7% |
| Benign Prostatic Hyperplasia |
5.3% |
| Mydriasis |
4.1% |
| Depression |
3.3% |
| Cataract Operation |
2.5% |
| Coronary Artery Disease |
2.5% |
| Blood Pressure Increased |
2.0% |
| Hyperlipidaemia |
2.0% |
| Gout |
1.6% |
| Prostate Cancer |
1.6% |
| Prostatic Disorder |
1.6% |
| Atrial Fibrillation |
1.2% |
| Bladder Disorder |
1.2% |
| Blood Pressure |
1.2% |
| Blood Pressure High |
1.2% |
| Glaucoma |
1.2% |
| Orthostatic Hypotension |
1.2% |
|
| Floppy Iris Syndrome |
10.4% |
| Renal Failure Acute |
9.1% |
| Drug Ineffective |
7.8% |
| Pancreatitis Acute |
7.8% |
| Pneumonia |
6.5% |
| Hypertension |
5.2% |
| Syncope |
5.2% |
| Vomiting |
5.2% |
| Circulatory Collapse |
3.9% |
| Completed Suicide |
3.9% |
| Death |
3.9% |
| Dizziness |
3.9% |
| Orthostatic Hypotension |
3.9% |
| Presyncope |
3.9% |
| Urinary Incontinence |
3.9% |
| Urticaria |
3.9% |
| Weight Decreased |
3.9% |
| Intestinal Polyp |
2.6% |
| Joint Swelling |
2.6% |
| Swelling Face |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
35.1% |
| Hypertension |
29.9% |
| Depression |
8.4% |
| Prophylaxis Against Renal Transplant Rejection |
3.9% |
| Blood Pressure |
1.9% |
| Blood Pressure High |
1.9% |
| Prophylaxis |
1.9% |
| Blood Pressure Increased |
1.3% |
| Blood Testosterone Decreased |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Coronary Artery Disease |
1.3% |
| Dysuria |
1.3% |
| Hyperthyroidism |
1.3% |
| Intentional Overdose |
1.3% |
| Mineral Supplementation |
1.3% |
| Periodontal Disease |
1.3% |
| Prostate Cancer |
1.3% |
| Prostatic Disorder |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Urinary Retention |
1.3% |
|
| Weight Loss Poor |
33.3% |
| Atrial Fibrillation |
5.1% |
| Drug Ineffective |
5.1% |
| Overdose |
5.1% |
| Paraesthesia |
5.1% |
| Rash Generalised |
5.1% |
| Urinary Retention |
5.1% |
| Urticaria |
5.1% |
| Blood Pressure Inadequately Controlled |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Epilepsy |
2.6% |
| Floppy Iris Syndrome |
2.6% |
| Growth Hormone Deficiency |
2.6% |
| Hypertension |
2.6% |
| Hypotension |
2.6% |
| Intentional Overdose |
2.6% |
| Metabolic Acidosis |
2.6% |
| Myocardial Infarction |
2.6% |
| Nocturia |
2.6% |
| Oedema Peripheral |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.8% |
| Hypertension |
18.5% |
| Product Used For Unknown Indication |
11.4% |
| Rheumatoid Arthritis |
4.3% |
| Prostate Cancer |
4.2% |
| Diabetes Mellitus |
3.1% |
| Prophylaxis |
3.1% |
| Renal Transplant |
2.4% |
| Blood Pressure |
2.3% |
| Pneumonia |
2.3% |
| Prophylaxis Against Renal Transplant Rejection |
2.0% |
| Depression |
1.9% |
| Low Density Lipoprotein Increased |
1.7% |
| Pain |
1.7% |
| Constipation |
1.5% |
| Emphysema |
1.5% |
| Nephrogenic Anaemia |
1.4% |
| Anxiety |
1.3% |
| Prostatic Disorder |
1.2% |
| Blood Cholesterol Increased |
1.2% |
|
| Vomiting |
12.0% |
| Paraesthesia |
9.4% |
| Renal Failure Acute |
8.5% |
| Urinary Tract Infection |
8.5% |
| Pain |
7.7% |
| Weight Decreased |
6.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
5.1% |
| Transient Ischaemic Attack |
4.3% |
| Drug Ineffective |
3.4% |
| Intraocular Pressure Increased |
3.4% |
| Renal Failure |
3.4% |
| Sepsis |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Ventricular Fibrillation |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
| Dysuria |
2.6% |
| Loss Of Consciousness |
2.6% |
| Myocardial Infarction |
2.6% |
| Pneumonia |
2.6% |
|
| Interacting |
| Hypertension |
43.8% |
| Type 2 Diabetes Mellitus |
18.8% |
| Benign Prostatic Hyperplasia |
6.3% |
| Cough |
6.3% |
| Erectile Dysfunction |
6.3% |
| Glaucoma |
6.3% |
| Ischaemic Heart Disease Prophylaxis |
6.3% |
| Pain |
6.3% |
|
| Drug Interaction |
33.3% |
| Renal Failure Acute |
33.3% |
| Syncope |
33.3% |
|
